Hol dir die App Get the App
⭐️⭐️⭐️⭐️⭐️
44 Bewertungen
Zur App
DAX 25.518,00 -1,35% Dow Jones 52.429,50 -0,64% MDAX 32.012,20 -1,21% Nikkei 225 64.147,50 -1,47% S&P 500 7.638,88 -0,39% STOXX Europe 50 6.298,75 -1,20% Nasdaq 100 29.415,80 -0,21% Bitcoin 78.221,52 USD 0,05% Gold 142,04 USD 0,41% EUR/USD 1,16 USD 0,07%
DAX 25.518,00 -1,35% Dow Jones 52.429,50 -0,64% MDAX 32.012,20 -1,21% Nikkei 225 64.147,50 -1,47% S&P 500 7.638,88 -0,39% STOXX Europe 50 6.298,75 -1,20% Nasdaq 100 29.415,80 -0,21% Bitcoin 78.221,52 USD 0,05% Gold 142,04 USD 0,41% EUR/USD 1,16 USD 0,07%
+49 (0) 172 414 333 6
Wertpapiere

Aktie US87918A1051

Teladoc Health Inc

0,00

  • 0,00
  • |
  • 0,00 %

Your browser does not support the canvas element.

  • 8:00
  • 9:00
  • 11:00
  • 13:00
  • 15:00
  • 17:00
  • 20:00
  • 22:00
  • 0.00
  • 1.30
  • 2.70
  • 4.00
  • 5.30

ERTRÄGE

Dieses Unternehmen zahlt derzeit keine Dividende. Mit einem Nettogewinn von -224 Mio. € und einem operativen Cashflow von 293 Mio. € hätte das Unternehmen die Kapazität für Ausschüttungen, verzichtet aber bewusst. Dies deutet auf strategische Reinvestitionen oder eine Phase intensiver Expansion hin.

0,00 €

Jährliche Dividende

0,00 %

Rendite

0,00 %

Dividenden-Wachstum

0,00 %

Ausschüttungsquote

  • 100 %

    G

  • 100 %

    OCF

UNTERNEHMEN

2,5 Mrd. $

Umsatz

  • -0,2 Mrd.

    NG

  • 283,1 Mio.

    F&E

  • 1,8 Mrd.

    BG

  • 2,5 Mrd.

    U

-1,61 %

Umsatz-Wachstum

  • 22

  • 23

  • 24

  • 25

  • 26

-0,2 Mrd. $

Nettogewinn

  • -15,6 %

    ROE
  • -8,8 %

    ROS
  • -7,0 %

    ROA
  • -7,0 %

    GPM

292,5 Mio. $

Operativer Cashflow

  • FCF

    88 %
  • 12 %

    CapEx

1,4 Mrd. $

Eigenkapital

  • EK 45 %
  • 55 % FK

4.620

Mitarbeiter

  • 547.229,2 $

    Umsatz / MA
  • -48.395,7 $

    Gewinn / MA

KGV

-6,29 $

KBV

0,98 $

KCV

5,48 $

KUV

0,56 $

EV/EBITDA

-12,36 $

EV/EBIT

-7,93 $

EV/FCF

8,51 $

EV/Umsatz

0,86 $

EnterpriseValue

2,2 Mrd. $

Eigenkapitalrendite

-15,60 %

Umsatzrendite

-8,84 %

EBIT-Marge

-10,88 %

EBITDA-Marge

-6,99 %

Kapitalumschlag

0,79 $

Gesamtkapitalrendite

-7,02 %

Eigenkapitalquote

0,45 $

Fremdkapitalquote

0,55 $

Verschuldungsgrad

1,22 $

Dyn. Verschuldungsgrad

5,98 $

Sachinvestitionsquote

-0,042 $

Anlagendeckungsgrad 1

1,27 $

Anlagendeckungsgrad 2

0,69 $

Liquidität 1. Grades

1,44 $

Liquidität 2. Grades

1,77 $

Liquidität 3. Grades

2,01 $

Dividende pro Aktie

0,00 $

Dividendenrendite

0,00 %

Ausschüttungsquote

0,00 %

Buchwert pro Aktie

8,21 $

Cashflow pro Aktie

1,68 $
Stand: 30.09.2025 TTM

Fakten

  • Sitz

    USA

  • Hauptsitz

    Purchase

  • Börsengang

    30.06.2015

  • Ausstehende Aktien

    174,63 Mio.

  • Mitarbeiter

    4,62 Tsd.

  • Währung

    USD

  • Sektor

    Gesundheitswesen

  • Industrie

    Medical - Healthcare Information Services

  • Börse

    NYSE

  • Ticker

    TDOC

  • Webseite

    teladochealth.com

Aktie

Unternehmensinfos

Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.